FDA Issues Warning to Cardinal Health Over Syringe Compliance
The FDA has issued a warning to Cardinal Health for marketing unapproved Monoject syringes, highlighting safety risks and compliance issues.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
